<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="20118">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02844998</url>
  </required_header>
  <id_info>
    <org_study_id>5191</org_study_id>
    <nct_id>NCT02844998</nct_id>
  </id_info>
  <brief_title>The Impact and Benefit of Physical Activity on Premature Ejaculation</brief_title>
  <acronym>PE</acronym>
  <official_title>The Impact and Benefit of Physical Activity on Premature Ejaculation: Results of a Prospective, Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the relationship between physical activity and
      PE, and determine whether moderate physical activity might delay ejaculation time or be an
      alternative treatment for PE.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>premature ejaculation diagnostic tool</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>intravaginal ejaculatory latency time</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Premature Ejaculation</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-controlled</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>physical activity</intervention_name>
    <description>patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Sham-controlled</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dapoxetine 30 mg on demand</intervention_name>
    <description>Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries</description>
    <arm_group_label>group 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sexually active, heterosexual patients without regular physical activity or erectile
             dysfunction, and had a sexual partner for at least six months, and sexual intercourse
             at least twice a week

        Exclusion Criteria:

          -  Use of medications for endocrinological, metabolic, chronic systemic, or psychiatric
             diseases, use of alcohol or addictive substances, or use of drugs that might affect
             erection and ejaculation, presence of patients with Peyronie's disease, chronic
             prostatitis, urethritis, or active urinary tract infection, and absence of regular
             physical activity or previous treatment for premature ejaculation.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95.</citation>
    <PMID>12900694</PMID>
  </results_reference>
  <results_reference>
    <citation>Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007 Aug;52(2):565-73. Epub 2007 Jan 16.</citation>
    <PMID>17275165</PMID>
  </results_reference>
  <results_reference>
    <citation>Sunay D, Sunay M, Aydoğmuş Y, Bağbancı S, Arslan H, Karabulut A, Emir L. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol. 2011 May;59(5):765-71. doi: 10.1016/j.eururo.2011.01.019. Epub 2011 Jan 18.</citation>
    <PMID>21256670</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 25, 2016</lastchanged_date>
  <firstreceived_date>July 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Muhammet Fatih Kilinc</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>intravaginal ejaculatory latency time</keyword>
  <keyword>international physical activity questionnaire</keyword>
  <keyword>premature ejaculation diagnostic tool</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Premature Ejaculation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
